Optometrists

Allowable Pharmaceutical Products

 

Updated List for PACE Providers

January 2005

 

The State Board of Optometry certifies the following classes of Optometrists.

 

Providers should examine the Optometrist license number for:

 

An “L” in the license indicates the optometrist may not utilize drugs.

A “P” in the license indicates the optometrist may utilize diagnostic drugs.

A “T” in the license indicates the optometrist may prescribe and administer pharmaceutical agents for therapeutic purposes.

A “G” in the license indicates the optometrist may also utilize drugs to treat glaucoma.

 

Optometrists who are properly certified may prescribe and administer the following pharmaceutical products of the A-rated generic therapeutically equivalent drug:

 

Updated July 2002

(1)    Topical anesthetics.

                        (i)   Proparacaine.

                           (ii)  Benoxinate.

                        (iii) Tetracaine.

            (2)   Topical ocular lubricants.

            (3)   Topical ophthalmic dyes and stains.

                        (i)   Fluorescein.

                        (ii)  Rose Bengal.

                           (iii) Fluorexen.

            (4)   Topical hyperosmotic agents.

            (5)   Autonomic drugs – topical only.

                        (i)   Cholinergic agonists.

                                    (A)  Pilocarpine nitrate and pilocarpine hydrochloride-diagnostic use only.

                                    (B)  Physostigmine.

                                    (C)  DFP (diisopropylfluorophosphate).

                                    (D)  Echothiopate.

                        (ii) Cholinergic antagonists.

                                    (A)  Homatropine hydrobromide.

                                    (B)  Tropicamide.

                                    (C)  Atropine sulfate.

                                    (D)  Cyclopentolate hydrochloride.

                                    (E)  Scopolamine hydrobromide.

                          (iii) Adrenergic agonists.

                                    (A)  Hydroxyamphetamine hydrobromide.

                                    (B)  Phenylephrine hydrochloride.

                                    (C)  Tetrahydrazoline.

                                    (D)  Nefazoline.

                                    (E)  Oxymetazoline.

                         (iv)  Adrenergic antagonists – diagnostic use only.

                                    (A) Dapiprazole.

                                    (B)  Thymoxamine.

           (6)  Nonsterodal anti-inflammatory drugs – topical only.

                         (i)  Diclofenac.

                        (ii)  Ketorolac.

                          (iii) Flurbiprofen.

                        (iv)  Suprofin.

         (7)  Antimicrobial agents.

                        (i)   Antibacterial – topical use only.

                                    (A)  Cell wall inhibitors.

                                                (I)   Bacitracin.

                                                (II)  Cephalosporins.

                                                (III) Penicillins.

                                                 (IV) Vancomycin.

                                    (B)  Protein synthesis inhibitors.

                                                (I)  Aminoglycosides.

                                                (II)  Tetracycline.

                                                (III) Erythromycin.

                                                (IV) Chloramphenicol.

                                    (C)  Intermediary metabolism inhibitors.

                                                  (I)  Sodium sulfacetamide and sulfisoxazole.

                                                  (II) Trimethoprim.

                                    (D)  DNA synthesis inhibitors.

                                                  (I)   Ciprofloxacin.

                                                (II)  Norfloxacin.

                                                 (III) Ofloxacin.

                                                (IV) Levofloxacin.

                                    (E)  Cell membrane permeability.

                                                  (I)    Polymyxin B.

                                                  (II)  Gramicidin.

                              (ii)  Antibacterial – oral.

                                    (A)  Cell wall inhibitors.

                                                  (I)   Penicillins – including in combination with clavulanic acid.

                                                (II)  Cephalosporins.

                                                                 (-1-)  First generation – cephalexin and cefadroxil.

                                                                 (-2-)  Second generation – cefaclor and cefuroxime.

                                    (B)  Protein synthesis inhibitors.

                                                   (I)   Tetracycline.

                                                   (II)  Doxycycline.

                                                   (III) Erythromycin.

                                                   (IV) Azithromycin.

                               (iii)  Antivirals – topical only.

                                    (A)  Idoxurine.

                                     (B)  Vidarabine.

                                      (C)  Trifluridine.

                               (iv)  Antivirals – oral.

                                    (A)  Acyclovir.

                                     (B)  Valacyclovir.

(C)     Famciclovir.

 

                                 (v)  Antifungal and antiparasitic – topical only.

                                    (A)  Amphotericin B, nystatin, natamycin.

                                     (B)  Miconazole, ketoconazole, clotrimazole.

                                     (C)  Thiabendazole.

                                     (D)  Neomycin and polymyxin B.

                                     (E)  Paromycin.

            (8)  Analgesic drugs – oral and topical.

                        (i)  Analgesic drugs – oral

                                    (A)  Codeine in combination with acetaminophen or aspirin

                                    (B)  Hydrocodone.

                                    (C)  Pentazocine.

                                    (D)  Propoxyphene.

                                    (E)  Tramadol.

                        (ii)  Antihistamines and mast cell stabilizers – topical only.

                                    (A)  Pheniramine.

                                    (B)  Pyrilamine.

                                    (C)  Antazoline.

                                    (D)  Levocarbastine

                                    (E)  Cromolyn.

                                    (F)  Nedocromil.

                                    (G)  Lodoxamide.

                                    (H)  Olopatadine.

                                    (I)   Pemirolast potassium.

                                    (J)   Emedastine difumarate.

                                    (K)  Azelastine hydrochloride.

                                    (L)  Ketotifen fumerate.

 

Additional Drugs Approved by the Department of Health

Approval of Drugs which may be Used by Certain Optometrists

 

Updated April,  2003

 

I.  Drugs for Approval for Use by all Therapeutically Certified Optometrists

            Topical Steroids

            prednisolone

            medrysone

            fluorometholone

            hydrocortisone

            dexamethasone

            rimexolone

            loteprednol

            triamcinolone

 

            Oral Steroids

prednisone

methylprednisolene

.

II.  Drugs for Approval for use by Optometrists Certified to Treat Glaucoma       

 

Beta Adrenergic Receptor Blocking Drugs

Nonselective  

timolol

levobunolol

metripranolol

carteolol

 

Selective

betaxolol

levobetaxlol

 

Cholinergic Receptor Agonists

Direct Acting

pilocarpine

carbachol

 

 

Indirect Acting

physostigmine

demecarium

echothiophate iodide

                                   

Adrenergic Receptor Agonists

Nonselective

epinephrine

dipivefrin

 

Selective Alpha 2 Agonists

            apraclonidine

            brimonidine

 

            Topical Carbonic Anhydrase Inhibitors

            dorzolamide

            brinzolamide

 

Prostaglandin Analogs

eicosanoid derivatives

latanoprost

travoprost

bimatoprost

docosanoid derivatives

unoprostone     

 

 

Approval of a Drug which may be Used by Certain Optometrists

 

Updated June, 2003

Topical Antibacterial

Povidone-iodine

 

Approval of Drugs which may be Used by Certain Optometrists

 

Updated October, 2003

Topical solutions:

moxifloxacin

gatifloxacin

cyclosporine ophthalmic emulsion

 

Topical solutions and products only, not oral or injectable formulations.

 

Approval of a Drug which may be Used by Certain Optometrists

 

Updated May, 2004

Elestat (epinastine HCL ophthalmic solution)